CLOV vs IBIO
Clover Health Investments Corp (CLOV) versus iBio, Inc. Common Stock (IBIO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IBIO revenue for 2025-06-30 was $400.0K. Net income was -$18.4M. Revenue was up 77.8% from 2024-06-30 to 2025-06-30. IBIO currently screens at market cap $13.4M.
CLOV currently screens at market cap $1.55B. IBIO currently screens at market cap $13.4M.
Not investment advice. Open the CLOV and IBIO stock pages for the full models.
Not investment advice.